Drug Trial Radar · NCT00696969
Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis
Last checked: Nov 19, 2026Latest source record: Feb 11, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
634
Actual
Start
Jun 2008
Primary completion
Jan 2010
Study completion Jan 2010
Sponsor
- Lead sponsor
- Drugs for Neglected DiseasesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 13, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The overall objective of this trial is to identify a safe and effective combination, (coadministration) short course treatment for the treatment of visceral leishmaniasis which could be easily deployed in a control programme and will reduce the risk of parasite resistance occurring. Safety and tolerability should be such that the combination can be easily deployed.
Conditions
- Visceral Leishmaniasis
Interventions
Amphotericin B DeoxycholateDrug
1 mg/kg e.o.d for 30 days
Ambisome + MiltefosineDrug
Ambisome (i.v. single dose 5 mg/kg)+ Miltefosine 7 days
Ambisome and ParomomycinDrug
Ambisome 5 mg/kg single dose + Paromomycin Sulphate 15mg/kg/day for 10 days
Miltefosine and ParomomycinDrug
Miltefosine (standard dose) and Paromomycin Sulphate 15mg/kg/day for 10 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Definitive cure based on parasitological clearance at Day 15 after start of combination therapy (Day 31 for standard therapy), no evidence of parasites at day 45 and no clinical signs or symptoms of VL at 6 months post treatment.Time frame: 6 months post treatment
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Kala-azar medical centre
Muzaffarpur, Bihar, India
Rajendra Memorial research Institute
Patna, Bihar, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.